RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL · Real-Time Price · USD
2.030
+0.030 (1.50%)
At close: Jul 3, 2025, 1:00 PM
1.990
-0.040 (-1.97%)
After-hours: Jul 3, 2025, 4:54 PM EDT

RedHill Biopharma Market Cap

RedHill Biopharma has a market cap or net worth of $4.66 million as of July 3, 2025. Its market cap has decreased by -63.02% in one year.

Market Cap
4.66M
Enterprise Value
398.55K
1-Year Change
-63.02%
Ranking
Category
Stock Price
$2.03

Market Cap Chart

Since January 7, 2013, RedHill Biopharma's market cap has decreased from $58.80M to $4.66M, a decrease of -92.08%. That is a compound annual growth rate of -18.37%.

History

DateMarket Cap% Change
Jul 3, 20252.60M-67.09%
Dec 31, 20247.90M68.09%
Dec 29, 20234.70M-47.78%
Dec 30, 20229.00M-92.54%
Dec 31, 2021120.70M-57.65%
Dec 31, 2020285.00M65.51%
Dec 31, 2019172.20M45.81%
Dec 31, 2018118.10M34.66%
Dec 29, 201787.70M-34.06%
Dec 30, 2016133.00M17.49%
Dec 31, 2015113.20M31.93%
Dec 31, 201485.80M37.28%
Dec 31, 201362.50M6.29%
View and export this data all the way back to 2013. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 700.84B
Johnson & Johnson 375.37B
AbbVie 334.34B
Novo Nordisk 306.47B
UnitedHealth Group 279.90B
Novartis AG 238.56B
Abbott Laboratories 233.90B
AstraZeneca 216.08B
Market Cap Rankings